The National Health Regulatory Authority (NHRA) announced that it had licensed the medical firm, which also the first facility to manufacture injectable drugs in the Kingdom of Bahrain.
The factory has thus obtained the rights to produce the initial batches of injectable drugs after presenting studies of the produced products and ensuring successful stability analyaes for them.
The injectable drugs will also be subjected to final inspection to be granted a Good Manufacturing Practices (GMP) certificate to start the production and marketing of sterile and injectable formulations.
